2m 2m 2m 2m 2m 2m 2m
ARVINAS (ARVN)
NASDAQ
$8.04+$0.30 (+3.88%)
Price as of Jun 23, 2026 7:57 PM EDT- $499.4MMarket Cap
- 4.59%1-Year Change
- BiotechnologyIndustry
ARVINAS (ARVN)
$8.04+$0.30 (+3.88%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 262.6M -0.30% | 263.4M +235.54% | 78.5M -40.26% | 131.4M +181.37% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 262.6M -0.30% | 263.4M +235.54% | 78.5M -40.26% | 131.4M +181.37% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -285.2M -18.09% | -348.2M -8.30% | -379.7M +20.54% | -315.0M +74.61% | |
Depreciation and Amortization Expense | 3.0M -34.78% | 4.6M -4.17% | 4.8M -23.81% | 6.3M +31.25% | |
Total Operating Expenses | 381.1M -25.80% | 513.6M +7.00% | 480.0M +21.64% | 394.6M +63.06% | |
Operating Profit | -118.5M -52.64% | -250.2M -37.68% | -401.5M +52.55% | -263.2M +34.77% | |
Interest Income | 38.4M -29.93% | 54.8M +41.24% | 38.8M +223.33% | 12.0M +531.58% | |
Interest Expense | N/A N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Interest Income and Expense and Net | 38.4M -29.93% | 54.8M +41.24% | 38.8M +223.33% | 12.0M +566.67% | |
Total Nonoperating Income and Expense | 38.0M -26.78% | 51.9M +38.03% | 37.6M +208.20% | 12.2M +183.72% | |
Income before Taxes | -80.5M -59.40% | -198.3M -45.51% | -363.9M +44.98% | -251.0M +28.52% | |
Income Taxes | 300,000 -50.00% | 600,000 -33.33% | 900,000 -95.69% | 20.9M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -80.8M -59.38% | -198.9M -45.85% | -367.3M +30.02% | -282.5M +47.91% | |
Net Income from Continuing Operations Applicable to Common | -80.8M -59.38% | -198.9M -45.85% | -367.3M +30.02% | -282.5M +47.91% | |
Basic EPS and Net Income | -1.14 -58.84% | -2.77 -58.16% | -6.62 +24.67% | -5.31 +39.01% | |
Diluted EPS and Net Income | -1.14 -58.84% | -2.77 -58.16% | -6.62 +24.67% | -5.31 +39.01% | |
Basic Weighted Average Shares | 70.9M -1.39% | 71.9M +29.55% | 55.5M +4.32% | 53.2M +6.40% | |
Diluted Weighted Average Shares | 70.9M -1.39% | 71.9M +29.55% | 55.5M +4.32% | 53.2M +6.40% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 142.9M +42.19% | 100.5M -67.76% | 311.7M +283.39% | 81.3M -24.93% | |
Short-Term Investments | 542.5M -42.22% | 938.9M -1.10% | 949.3M -15.54% | 1.1B -19.39% | |
Cash and Cash Equivalents and Short-Term Investments | 685.4M -34.06% | 1.0B -17.57% | 1.3B +4.62% | 1.2B -19.79% | |
Total Current Assets | 700.7M -34.35% | 1.1B -16.63% | 1.3B +3.23% | 1.2B -20.12% | |
Accumulated Depreciation | 28.2M +10.16% | 25.6M +21.33% | 21.1M +27.11% | 16.6M +53.70% | |
Property and Plant and Equipment and Net | 5.2M -25.71% | 7.0M -39.13% | 11.5M -14.18% | 13.4M +5.51% | |
Total Long-Term Assets | 5.2M -25.71% | 7.0M -39.13% | 11.5M -14.18% | 13.4M +5.51% | |
Total Assets | 717.9M -34.22% | 1.1B -16.34% | 1.3B +2.82% | 1.3B -19.78% | |
Income Taxes Payable | 4.8M +50.00% | 3.2M +357.14% | 700,000 -93.20% | 10.3M N/A | |
Total Short-Term Debt | 200,000 0.00% | 200,000 0.00% | 200,000 N/A | N/A N/A | |
Total Current Liabilities | 142.5M -37.99% | 229.8M -10.62% | 257.1M -12.88% | 295.1M +12.76% | |
Total Long-Term Debt | 400,000 -33.33% | 600,000 -25.00% | 800,000 -20.00% | 1.0M 0.00% | |
Total Long-Term Liabilities | 141.5M -52.82% | 299.9M -22.61% | 387.5M -5.21% | 408.8M -24.04% | |
Total Liabilities | 284.0M -46.38% | 529.7M -17.83% | 644.6M -8.42% | 703.9M -12.00% | |
Retained Earnings | -1.6B +5.28% | -1.5B +14.92% | -1.3B +38.05% | -965.4M +41.37% | |
Total Stockholders Equity | 433.9M -22.75% | 561.7M -14.89% | 660.0M +16.83% | 564.9M -27.73% | |
Total Shares Outstanding | 63.5M -7.70% | 68.8M +1.18% | 68.0M +27.82% | 53.2M +0.38% | |
Cash Flow | |||||
Cash from Operating Activities | -273.8M +5.59% | -259.3M -25.45% | -347.8M +27.17% | -273.5M -148.89% | |
Capital Expenditures | 1.9M +5.56% | 1.8M -37.93% | 2.9M -57.35% | 6.8M +44.68% | |
Cash from Investing Activities | 407.6M +1,074.64% | 34.7M -82.95% | 203.5M -16.19% | 242.8M +118.48% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -91.4M -1,256.96% | 7.9M -97.89% | 374.7M +7,872.34% | 4.7M -98.31% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -45.13% -52.49% | -94.99% -81.43% | -511.46% +155.34% | -200.30% -52.10% | |
Return on Assets | -8.93% -46.20% | -16.60% -41.84% | -28.55% +44.01% | -19.82% +19.29% | |
Return on Equity | -16.23% -50.15% | -32.56% -45.71% | -59.97% +42.94% | -41.96% +56.40% | |
Revenue Growth | -0.30% -100.13% | 235.54% +685.07% | -40.26% -122.20% | 181.37% +58.81% | |
Current Ratio | 4.92 +5.87% | 4.64 -6.73% | 4.98 +18.48% | 4.20 -29.16% | |
Cash Ratio | 1.00 +129.32% | 0.44 -63.93% | 1.21 +340.07% | 0.28 -33.42% | |
Debt-to-Equity Ratio | 0.001 0.00% | 0.001 -6.67% | 0.002 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.0008 +14.29% | 0.0007 -12.50% | 0.0008 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow